Javier Zarranz-Ventura, Sonia Marías-Pérez, Ruben Martin-Pinardel, Manel Fernandez-Bonet, Begoña Pina-Marin, Estefanía Cobos, Carmen Antía Rodríguez-Fernandez, Alba Parrado-Carrillo, Isaac Alarcón-Valero, Carles Barnes, Esther Cilveti, Julia Aramburu-Claveria, Francisco J Ascaso-Puyuelo, Pilar Calvo, Maria Pilar Ruiz-Del-Tiempo, Gabriela Susanna-González, Marc Figueras-Roca, Ricardo P Casaroli-Marano, Carolina Bernal-Morales, Fight Retinal Blindness Spain (FRB Spain) investigators
چکیده
To evaluate clinical outcomes, treatment intervals, and safety outcomes of brolucizumab (BRO) treatment in a national neovascular age-related macular degeneration (nAMD) database. Multicentre, national, routine clinical care database study of nAMD eyes receiving ≥1 BRO injection. Demographics,…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1038/s41433-025-03871-6